Raphael Darcy

3.2k citations

63 papers · 2.8k indexed · h-index 35

Pharmaceutical Science top 0.5%
- Drug Solubulity and Delivery Systems 7
Biomaterials top 1%
- Nanoparticle-Based Drug Delivery 8
Organic Chemistry top 2%
- Surfactants and Colloidal Systems 10
- Carbohydrate Chemistry and Synthesis 8
- Supramolecular Chemistry and Complexes 6
Molecular Biology top 5%
- RNA Interference and Gene Delivery 25
- Advanced biosensing and bioanalysis techniques 16
- Lipid Membrane Structure and Behavior 6
Spectroscopy top 5%

Co-authors: Bart Jan Ravoo Caitríona M. O’Driscoll Antonino Mazzaglia Florence Sallas Jianfeng Guo Ruth Donohue John F. Cryan Julien Ogier
Cited by: Pharmaceutical Science Biomaterials Organic Chemistry
Journals: International Journal of Pharmaceutics (6 papers)Molecular Pharmaceutics (4 papers)Organic & Biomolecular Chemistry (3 papers)
Partner nations: Ireland Italy United States

In The Last Decade

Raphael Darcy

62 papers receiving 2.8k citations

Peers

Countries citing papers authored by Raphael Darcy

Since Specialization

Citations

This map shows the geographic impact of Raphael Darcy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael Darcy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael Darcy more than expected).

Fields of papers citing papers by Raphael Darcy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphael Darcy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael Darcy. The network helps show where Raphael Darcy may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Raphael Darcy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Raphael Darcy Line = papers co-authored together Raphael Darcy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Self-Assembled Cationic β-Cyclodextrin Nanostructures for siRNA Delivery Molecular Pharmaceutics ·Rigoberto Juárez Carbajal,Tania Hidalgo,Pierre‐André Cazade,Raphael Darcy,Michael F. Cronin,Amaury Méndez Guerrero,Caitríona M. O’Driscoll,Damien Thompson	2019	49
2	Cyclodextrin-siRNA conjugates as versatile gene silencing agents European Journal of Pharmaceutical Sciences ·Meenakshi Malhotra,Myoung-Jung Kim,James Evans,Daniel O’Driscoll,Raphael Darcy,Caitríona M. O’Driscoll	2017	31
3	Folate-targeted amphiphilic cyclodextrin.siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged circulation in vivo Nanomedicine Nanotechnology Biology and Medicine ·James Evans,Meenakshi Malhotra,Jianfeng Guo,Joseph P. O’Shea,Muhamamd Nurul Huda,Amanda O’Neill,Zhou Bin,Brendan T. Griffin,Raphael Darcy,R. William G. Watson,Caitríona M. O’Driscoll	2016	47
4	A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor International Journal of Pharmaceutics ·Kathleen A. Fitzgerald,Meenakshi Malhotra,Myoung-Jung Kim,Florence Sallas,James Evans,Raphael Darcy,Caitríona M. O’Driscoll	2015	68
5	The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeutics Biomaterials ·Kathleen A. Fitzgerald,Jianfeng Guo,Khalid Assalaou,Caroline M. Curtin,Meenakshi Malhotra,Raphael Darcy,Fergal J. O’Brien,Caitríona M. O’Driscoll	2015	93
6	Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: In vitro analysis European Journal of Pharmaceutical Sciences ·Myoung-Jung Kim,Meenakshi Malhotra,David McCarthy,Bruno M.D.C. Godinho,John F. Cryan,Raphael Darcy,Caitríona M. O’Driscoll	2015	62
7	Biophysical and Structural Characterisation of Nucleic Acid Complexes with Modified Cyclodextrins Using Circular Dichroism Journal of Pharmaceutical Sciences ·Aoife O’Mahony,Michael F. Cronin,I. V. Bogorodskaya,James Evans,Kathleen Daly,Raphael Darcy,Caitríona M. O’Driscoll	2014	13
8	PEGylated cyclodextrins as novel siRNA nanosystems: Correlations between polyethylene glycol length and nanoparticle stability International Journal of Pharmaceutics ·Bruno M.D.C. Godinho,Julien Ogier,Aoife Quinlan,Raphael Darcy,Brendan T. Griffin,John F. Cryan,Caitríona M. O’Driscoll	2014	45
9	Gastrointestinal gene delivery by cyclodextrins – In vitro quantification of extracellular barriers International Journal of Pharmaceutics ·Martin O’Neill,Aoife O’Mahony,C.J. Byrne,Raphael Darcy,Caitríona M. O’Driscoll	2013	14
10	Differential nanotoxicological and neuroinflammatory liabilities of non-viral vectors for RNA interference in the central nervous system Biomaterials ·Bruno M.D.C. Godinho,David McCarthy,Cristina Torres‐Fuentes,Caroll J. Beltrán,Joanna McCarthy,Aoife Quinlan,Julien Ogier,Raphael Darcy,Caitríona M. O’Driscoll,John F. Cryan	2013	35
11	Cationic and PEGylated Amphiphilic Cyclodextrins: Co-Formulation Opportunities for Neuronal Sirna Delivery PLoS ONE ·Aoife O’Mahony,Julien Ogier,Raphael Darcy,John F. Cryan,Caitríona M. O’Driscoll	2013	34
12	Anisamide-targeted cyclodextrin nanoparticles for siRNA delivery to prostate tumours in mice Biomaterials ·Jianfeng Guo,Julien Ogier,Stéphane Desgranges,Raphael Darcy,Caitríona M. O’Driscoll	2012	108
13	A click chemistry route to 2-functionalised PEGylated and cationic β-cyclodextrins: co-formulation opportunities for siRNA delivery Organic & Biomolecular Chemistry ·Aoife O’Mahony,Julien Ogier,Stéphane Desgranges,John F. Cryan,Raphael Darcy,Caitríona M. O’Driscoll	2012	62
14	Self-assembling Modified β-Cyclodextrin Nanoparticles as Neuronal siRNA Delivery Vectors: Focus on Huntington’s Disease Molecular Pharmaceutics ·Bruno M.D.C. Godinho,Julien Ogier,Raphael Darcy,Caitríona M. O’Driscoll,John F. Cryan	2012	102
15	Therapeutic targeting in the silent era: advances in non-viral siRNA delivery Molecular BioSystems ·Jianfeng Guo,Karen A. Fisher,Raphael Darcy,John F. Cryan,Caitríona M. O’Driscoll	2010	84
16	Cell transfection with polycationic cyclodextrin vectors European Journal of Pharmaceutical Sciences ·Sally‐Ann Cryan,Gadis Mahkota Negara,Ruth Donohue,Raphael Darcy,Caitríona M. O’Driscoll	2004	111
17	Multivalent binding of galactosylated cyclodextrin vesicles to lectin Organic & Biomolecular Chemistry ·Antonino Mazzaglia,Tyler Reuss,Domenico Garozzo,Regina Issuzu Hirooka de Borba,Bart Jan Ravoo,Raphael Darcy	2004	47
18	Bilayer Vesicles of Amphiphilic Cyclodextrins: Host Membranes That Recognize Guest Molecules Chemistry - A European Journal ·Rtt Forman,Choon Woo Lim,Raphael Darcy,Tobias Revermann,Uwe Kärst,Marcel Giesbers,Antonius T. M. Marcelis,Adina N. Lazar,Anthony W. Coleman,David N. Reinhoudt,Bart Jan Ravoo	2004	166
19	Novel Heterotopic Colloids of Anionic Porphyrins Entangled in Cationic Amphiphilic Cyclodextrins: Spectroscopic Investigation and Intracellular Delivery Chemistry - A European Journal ·Antonino Mazzaglia,Nicola Angelini,Raphael Darcy,Ruth Donohue,Domenico Lombardo,Norberto Micali,Maria Teresa Sciortino,Valentina Villari,Luigi Monsù Scolaro	2003	66
20	Cationic β-cyclodextrin bilayer vesicles Chemical Communications ·Ruth Donohue,Antonino Mazzaglia,Bart Jan Ravoo,Raphael Darcy	2002	84

About Raphael Darcy

Raphael Darcy is a scholar working on Pharmaceutical Science, Organic Chemistry, Biomaterials, Molecular Biology and Biophysics, having authored 63 papers that have together received 2.8k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (25 papers), Advanced biosensing and bioanalysis techniques (16 papers), Surfactants and Colloidal Systems (10 papers), Nanoparticle-Based Drug Delivery (8 papers), Carbohydrate Chemistry and Synthesis (8 papers), Drug Solubulity and Delivery Systems (7 papers), Lipid Membrane Structure and Behavior (6 papers) and Supramolecular Chemistry and Complexes (6 papers). The work is most often cited by research in Pharmaceutical Science (485 citations), Biomaterials (856 citations), Organic Chemistry (748 citations), Molecular Biology (1.6k citations) and Spectroscopy (327 citations). Raphael Darcy has collaborated with scholars based in Ireland, Italy and United States. Frequent co-authors include Bart Jan Ravoo, Caitríona M. O’Driscoll, Antonino Mazzaglia, Florence Sallas, Jianfeng Guo, Ruth Donohue, John F. Cryan, Julien Ogier, Meenakshi Malhotra and Bruno M.D.C. Godinho. Their work appears in journals such as International Journal of Pharmaceutics, Molecular Pharmaceutics, Organic & Biomolecular Chemistry, European Journal of Pharmaceutical Sciences and Biomaterials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact